⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
FBLG News
FibroBiologics, Inc. Common Stock
Form 8-K
sec.gov
FBLG
FibroBiologics Announces Closing of $3 Million Public Offering
globenewswire.com
FBLG
FibroBiologics Announces Pricing of $3 Million Public Offering
globenewswire.com
FBLG
FibroBiologics Announces Successful Manufacturing of CYWC628 Drug Product to Support Upcoming Diabetic Foot Ulcer Clinical Trial
globenewswire.com
FBLG
FibroBiologics Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Bid Price Requirement
globenewswire.com
FBLG
The $45 Billion Cell Therapy Boom Just Hit a Manufacturing Milestone Most Investors Haven’t Noticed
globenewswire.com
FBLG
FATE
MESO
LGVN
FibroBiologics Announces Advances in Burn Treatment Using Proprietary Fibroblast Spheroid Technology
globenewswire.com
FBLG
Form 8-K
sec.gov
FBLG
FibroBiologics Completes Site Onboarding for Phase 1/2 Clinical Trial for CYWC628 for the Treatment of Refractory Diabetic Foot Ulcers
globenewswire.com
FBLG
Cell Therapies Moving From Lab to Factory Floor, and the Stocks Behind Them
prnewswire.com
FBLG
MESO
LGVN
FATE